Latest Ratings for QRVO Date Firm Action From To Mar 2022 Morgan Stanley Downgrades Overweight Equal-Weight Feb 2022 Benchmark Maintains Buy Feb 2022 Mizuho Maintains Neutral View More Analyst Ratings for QRVO View the Latest Analyst Ratings read more
Latest Ratings for BLK Date Firm Action From To Mar 2022 Exane BNP Paribas Downgrades Outperform Neutral Feb 2022 Deutsche Bank Maintains Buy Jan 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for BLK View the Latest Analyst Ratings read more
Channel Therapeutics shares rise after announcing 10-for-1 reverse stock split and upcoming rebrand. read more
The natural gas market is on the verge of a rapid increase in demand as heatwaves continue to sweep through key areas of the U.S. and Europe. read more
The 2025 TIME 100 Most Influential Companies list includes over 40 companies that investors can buy stock in. read more
FDA approved label changes for Breyanzi and Abecma, easing access by reducing monitoring rules and eliminating REMS safety program requirements. read more